Study helps understand how RNA modification promotes pancreatic cancer

Chemical modifications of RNA molecules, such as m6A, can critically impact gene expression, influencing various aspects of cancer development and progression.

Triastek and BioNTech to develop 3D printed RNA therapeutics

The collaboration is aimed at advancing oral RNA therapeutics with distinct external and internal geometries. Credit: Pickadook / Shutterstock. BioNTech and Triastek have entered a

July 24, 2024

STAT Virtual Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us

December 1, 2023

MarketingRx roundup: Genentech, Bristol Myers lead Fast Company innovators list; Real Chemistry inks AI deal

Genentech in the biotech category and Bristol Myers Squibb in the pharmaceutical category notched top spots on Fast Company’s annual best workplaces for innovators list

July 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.